# AbbVie Inc. (ABBV) — Q1-2022 Earnings Results

**Report date:** 2022-04-29 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2022

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 6.03%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.16 | N/A | +0.48% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Management acknowledged the challenges in the current market environment. They emphasized their commitment to long-term growth without providing detailed guidance.

**Key quotes:**

> Management did not provide specific revenue figures or guidance for the upcoming quarters.

> The company expressed a focus on maintaining operational stability.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by over 6% likely due to a lack of revenue details and future guidance, which may have raised concerns among investors about the company's outlook.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2022_